Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Oct 26;12:1015235. doi: 10.3389/fonc.2022.1015235

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Wang, Liu, Shen, Xiao, Zhou, Cheng, Hu, Fan, Ni, Xu, Zhang and Yang

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

The relationship between the risk model and immunotherapy or TMB. (A–F) Drug sensitivity of patients with different risk patterns. (G) The relationship between risk score value and TMB level. (H, I) TMB status of the top 20 genes was visualized in two groups. (J) TIDE score of patients in two risk groups. (K) The survival outcome of the patients with different TMB levels. (L) The prognosis of patients with different tumor mutation burdens and different risk patterns was accessed. ***p < 0.001.